Cover image of the article: Development and Evaluation of a Real-Time TaqMan-PCR for the Detection of Human Cytomegalovirus DNA in Bone Marrow Transplant Recipients

Image Credit:Shiraz E-Med J

Development and Evaluation of a Real-Time TaqMan-PCR for the Detection of Human Cytomegalovirus DNA in Bone Marrow Transplant Recipients

Authors

H Ghaffari1,*, O Obeidi2, M Dehghan1, B Chahardouli1, K Alimoghaddam1, A Gharebaghian2, AR Shamshiri1, A Ghavamzadeh1
1Assistant Professor, Hematology, Oncology and Bone Marrow Transplantation Research Center; Tehran University of Medical Sciences, Tehran, Iran
2Research Assistant, Iran Blood Transfusion Organization Research Center, Tehran, Iran
*Corresponding Author: Faculty member at Hematology, Oncology and BMT Research Center, Tehran University Medical Sciences, Shariati Hospital, Tehran, Iran. Tel.: +98-2184902638, Fax: +98-2188004140, E-mail: shghaffari2000@yahoo.com. Email: shghaffari2000@yahoo.com

Shiraz E-Medical Journal:Vol. 7, issue 3; e93680
Published online:Jul 01, 2006
Article type:Research Article
Received:May 14, 2019
Accepted:Jul 01, 2006
How to Cite:Ghaffari H, Obeidi O, Dehghan M, Chahardouli B, Alimoghaddam K, et al. Development and Evaluation of a Real-Time TaqMan-PCR for the Detection of Human Cytomegalovirus DNA in Bone Marrow Transplant Recipients. Shiraz E-Med J. 2006;7(3):e93680. doi:

Abstract

Introduction: Cytomegalovirus (CMV) has been recognized as the most important viral pathogen in persons undergoing
bone marrow transplantation (BMT). In this study, we present the development of a TaqMan-based real-time PCR
assay to quantify human cytomegalovirus (CMV) DNA in peripheral blood leukocytes (PBLs) of bone marrow transplantation
patients.

Materials and Methods: A plasmid containing the target sequence from the pp65 region (UL83) of CMV was constructed
as a positive control template. Serial dilutions of 107 to 101 plasmids per assay were prepared. Peripheral blood
samples were collected from patients after transplantation. CMV DNA was quantified by RQ-PCR in parallel with the
pp65 antigenemia assay in PBL samples.

Results: The real-time PCR assay could detect CMV DNA in patient's samples with a wide linear range, from 10 to over
107 copies of CMV. Real-time PCR assay results correlated with those of the CMV pp65 antigenemia assay (P < 0.0001).

Discussion: The TaqMan assay may be a useful tool for rapid quantification of CMV infection and for monitoring of
CMV reactivation in bone marrow transplantation recipients. The results of both quantitative assays were significantly
correlated; however, the RQ-PCR assay was more sensitive than the pp65 antigenemia assay.

Highlights

References

  • 1.
    The references are available in the PDF file.

Copyright

© 2006, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

30
Jul
2023
Detection of Mycobacterium tuberculosis in Peripheral Blood Mononuclear Cells from Patients with Pulmonary Tuberculosis

Detection of Mycobacterium tuberculosis in Peripheral Blood Mononuclear Cells from Patients with Pulmonary Tuberculosis

Farimah Yarmohammadi,
Ali Farhadi,
Narges Hassanaghaei,
Gholamreza Rafiei Dehbidi,
Farzaneh Zarghampoor,
Ehsan Farzanfar
,et al.

Yarmohammadi F, Farhadi A, Hassanaghaei N, Rafiei Dehbidi G, Zarghampoor F, et al. Detection of Mycobacterium tuberculosis in Peripheral Blood Mononuclear Cells from Patients with Pulmonary Tuberculosis. Jundishapur J Microbiol. 2023;16(6):e134575. doi: https://doi.org/10.5812/jjm-134575

31
Aug
2015
Development of an In-House TaqMan Real Time RT-PCR Assay to Quantify Hepatitis C Virus RNA in Serum and Peripheral Blood Mononuclear Cells in Patients With Chronic Hepatitis C Virus Infection

Development of an In-House TaqMan Real Time RT-PCR Assay to Quantify Hepatitis C Virus RNA in Serum and Peripheral Blood Mononuclear Cells in Patients With Chronic Hepatitis C Virus Infection

Bahman Khalvati Fahlyani,
Abbas Behzad-Behbahani,
Seiied Alireza Taghavi,
Ali Farhadi,
Saeede Salehi,
Setare Adibzadeh
,et al.

Khalvati Fahlyani B, Behzad-Behbahani A, Taghavi SA, Farhadi A, Salehi S, et al. Development of an In-House TaqMan Real Time RT-PCR Assay to Quantify Hepatitis C Virus RNA in Serum and Peripheral Blood Mononuclear Cells in Patients With Chronic Hepatitis C Virus Infection. Hepat Mon. 2015;15(8):e28895. doi: https://doi.org/10.5812/hepatmon.28895

8
Nov
2020
In Vitro Replication of HCV RNA in Peripheral Blood Mononuclear Cells Isolated from Patients Undergoing Treatment for Hepatitis C Virus Infection

In Vitro Replication of HCV RNA in Peripheral Blood Mononuclear Cells Isolated from Patients Undergoing Treatment for Hepatitis C Virus Infection

Golnoosh Zarnegar,
Ali Farhadi,
Noorossadat Seyyedi,
Farzaneh Aboualizadeh,
Reza Ranjbaran,
Ehsan Farzanfar
,et al.

Zarnegar G, Farhadi A, Seyyedi N, Aboualizadeh F, Ranjbaran R, et al. In Vitro Replication of HCV RNA in Peripheral Blood Mononuclear Cells Isolated from Patients Undergoing Treatment for Hepatitis C Virus Infection. Hepat Mon. 2020;20(9):e108070. doi: https://doi.org/10.5812/hepatmon.108070

29
Oct
2025
Towards Routine Molecular Diagnostics: Multiplex SYBR Green Real-time PCR for Rapid Molecular Screening of Recurrent Translocations in Acute Myeloid Leukemia

Towards Routine Molecular Diagnostics: Multiplex SYBR Green Real-time PCR for Rapid Molecular Screening of Recurrent Translocations in Acute Myeloid Leukemia

Farzaneh Tavakoli,
Hamide Rahmani Seraji,
Elham Roshandel,
Fatemeh Karimpour,
Hoda Hasheminasab,
Nader Vazifeh Shiran
,et al.

Tavakoli F, Rahmani Seraji H, Roshandel E, Karimpour F, Hasheminasab H, et al. Towards Routine Molecular Diagnostics: Multiplex SYBR Green Real-time PCR for Rapid Molecular Screening of Recurrent Translocations in Acute Myeloid Leukemia. Int J Cancer Manag. 2025;18(1):e166704. doi: https://doi.org/10.5812/ijcm-166704

8
Sep
2021
Evaluation of Cytomegalovirus Infections in Liver Transplant Recipients Under Universal Prophylaxis: A Single Centre Experience

Evaluation of Cytomegalovirus Infections in Liver Transplant Recipients Under Universal Prophylaxis: A Single Centre Experience

Sibel Altunisik Toplu,
Adem Kose,
Serdar Karakas,
Yasar Bayindir,
Baris Otlu,
Sezai Yilmaz

Altunisik Toplu S, Kose A, Karakas S, Bayindir Y, Otlu B, et al. Evaluation of Cytomegalovirus Infections in Liver Transplant Recipients Under Universal Prophylaxis: A Single Centre Experience. Hepat Mon. 2021;21(6):e115370. doi: https://doi.org/10.5812/hepatmon.115370

More by these authors

H GhaffariPubMedScholar
M DehghanPubMedScholar
B ChahardouliPubMedScholar
K AlimoghaddamPubMedScholar
A GharebaghianPubMedScholar
AR ShamshiriPubMedScholar
A GhavamzadehPubMedScholar
Share
Cited by
Metrics